Kwang Dong Pharmaceutical Company Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Kwang Dong Pharmaceutical Company Limited with three other
companies in this sector in South Korea:
Hanmi Science Company Limited
sales of 776.22 billion Korean Won [US$683.07 million]
of which 77%
was Pharmaceutical Sales),
Daewoong Company Limited
(996.65 billion Korean Won [US$877.05 million]
of which 105%
was Medicinal Manufacturing & Selling), and
Daewoong Pharmaceutical Company Limited
(839.69 billion Korean Won [US$738.92 million]
of which 100%
was Medicine Manufacture&Sale).
During the year ended December of 2015, sales at
Kwang Dong Pharmaceutical Company Limited were 955.45 billion Korean Won (US$840.80 million).
increase of 82.9%
versus 2014, when the company's sales were 522.27 billion Korean Won.
This was the fifth consecutive year of sales increases at Kwang Dong Pharmaceutical Company Limited
(and since 2010, sales have increased a total of 230%).
Sales of Pharmacy Operations saw an increase
13.0% in 2015, from
146.05 billion Korean Won to 165.09 billion Korean Won.
Not all segments of Kwang Dong Pharmaceutical Company Limited experienced an increase in sales in 2015:
sales of Other fell 41.6% to 12.08 billion Korean Won.
(However, this segment's sales were only a very small portion of the company's overall sales).